Bill Maughan – Canaccord Genuity

Canaccord Genuity

A Canaccord Genuity analyst with 10 tracked ratings across 9 distinct tickers has a 40% success rate on the captured sample, focusing on ratings from two sources.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

10 months ago

2025-08-06 00:00:00+00

Track record

Aggregated

40% success rate

Bullish: 0
Hold: 3
Bearish: 0

Aggregated

Not available

Bullish: 4
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
YMABY-MABS THERAPEUTICS INC	2025-08-06	hold	$8.60	Aggregated
FATE	2024-05-10	buy	$9.00	Aggregated
NKTX	2024-05-10	buy	$15.00	Aggregated
NKTX	2024-03-26	buy	$16.00	Aggregated
NKTXNKARTA INC	2024-03-26	unknown	$16.00	Aggregated
IPSC	2024-03-15	buy	$24.00	Aggregated
IMCRIMMUNOCORE HOLDINGS PLC - ADR	2024-02-29	hold	$63.00	Aggregated
MRNAMODERNA INC	2024-02-23	hold	$91.00	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	2024-02-21	unknown	$60.00	Aggregated
MRUSMERUS N.V	2023-11-02	unknown	$45.00	Aggregated

Tickers covered(9)

Ticker	Ratings	Last rating	Sources
YMABY-MABS THERAPEUTICS INC	1	2025-08-06	Aggregated
FATE	1	2024-05-10	Aggregated
NKTX	2	2024-05-10	Aggregated
NKTXNKARTA INC	1	2024-03-26	Aggregated
IPSC	1	2024-03-15	Aggregated
IMCRIMMUNOCORE HOLDINGS PLC - ADR	1	2024-02-29	Aggregated
MRNAMODERNA INC	1	2024-02-23	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	1	2024-02-21	Aggregated
MRUSMERUS N.V	1	2023-11-02	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.